95 related articles for article (PubMed ID: 23339665)
1. A Kampo formula, saikokaryukotsuboreito, improves serum testosterone levels of castrated mice and its possible mechanism.
Michihara S; Shin N; Watanabe S; Morimoto Y; Okubo T; Norimoto H
Aging Male; 2013 Mar; 16(1):17-21. PubMed ID: 23339665
[TBL] [Abstract][Full Text] [Related]
2. A herbal medicine, saikokaryukotsuboreito, improves serum testosterone levels and affects sexual behavior in old male mice.
Zang ZJ; Ji SY; Dong W; Zhang YN; Zhang EH; Bin Z
Aging Male; 2015 Jun; 18(2):106-11. PubMed ID: 25259618
[TBL] [Abstract][Full Text] [Related]
3. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of Japanese traditional herbal medicine (Kampo) in patients with late-onset hypogonadism.
Amano T; Imao T; Takemae K
Aging Male; 2010 Sep; 13(3):166-73. PubMed ID: 20143961
[TBL] [Abstract][Full Text] [Related]
5. Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice.
Zang ZJ; Ji SY; Zhang YN; Gao Y; Zhang B
Chin Med J (Engl); 2016 Apr; 129(7):846-53. PubMed ID: 26996482
[TBL] [Abstract][Full Text] [Related]
6. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms.
Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Nonomura N; Okuyama A
Aging Male; 2008 Jun; 11(2):95-9. PubMed ID: 18570062
[TBL] [Abstract][Full Text] [Related]
8. Androgen-dependent miR-125a-5p targets LYPLA1 and regulates global protein palmitoylation level in late-onset hypogonadism males.
Qu M; Zhao Y; Qing X; Zhang X; Li H
J Cell Physiol; 2021 Jun; 236(6):4738-4749. PubMed ID: 33284463
[TBL] [Abstract][Full Text] [Related]
9. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
Turchi P; Simi S; Pescatori ES
J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
[TBL] [Abstract][Full Text] [Related]
10. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients].
Taniguchi H; Kawa G; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556
[TBL] [Abstract][Full Text] [Related]
11. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?
Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A
Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356
[TBL] [Abstract][Full Text] [Related]
12. Puerariae radix prevents bone loss in castrated male mice.
Wang X; Wu J; Chiba H; Yamada K; Ishimi Y
Metabolism; 2005 Nov; 54(11):1536-41. PubMed ID: 16253645
[TBL] [Abstract][Full Text] [Related]
13. Treatment of climacteric symptoms with herbal formulas of traditional Chinese medicine.
Pan B; Kato Y; Sengoku K; Takuma N; Niizeki N; Ishikawa M
Gynecol Obstet Invest; 2004; 57(3):144-8. PubMed ID: 14707474
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
[TBL] [Abstract][Full Text] [Related]
15. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
Lunenfeld B; Saad F; Hoesl CE
Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.
Amano T; Imao T; Takemae K; Iwamoto T; Nakanome M
Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793
[TBL] [Abstract][Full Text] [Related]
17. Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.
Iwamoto T; Yanase T; Horie H; Namiki M; Okuyama A
Int J Urol; 2009 Feb; 16(2):168-74. PubMed ID: 19054164
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
19. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
Mäkinen JI; Huhtaniemi I
Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
[TBL] [Abstract][Full Text] [Related]
20. [Bone and Men's Health. Late-onset hypogonadism in males and male menopause (andropause)].
Komiya A; Watanabe A; Fuse H
Clin Calcium; 2010 Feb; 20(2):234-44. PubMed ID: 20118516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
